{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"12"},{"groupId":"OG006","value":"3"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"}],"title":"Not evaluable"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"}],"title":"Complete response"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"1"}],"title":"Partial response"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"2"},{"groupId":"OG008","value":"1"}],"title":"Stable disease"},{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"4"},{"groupId":"OG008","value":"1"}],"title":"Progressive disease"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"15"},{"groupId":"OG006","value":"5"},{"groupId":"OG007","value":"7"},{"groupId":"OG008","value":"3"}],"units":"Participants"}],"description":"Due to the early termination of the study, data for efficacy endpoints were insufficient for the planned efficacy analyses.","groups":[{"description":"ASN002 10 mg BID","id":"OG000","title":"10 mg BID"},{"description":"ASN002 20 mg BID","id":"OG001","title":"20 mg BID"},{"description":"ASN002 30 mg BID","id":"OG002","title":"30 mg BID"},{"description":"ASN002 40 mg BID","id":"OG003","title":"40 mg BID"},{"description":"ASN002 50 mg BID","id":"OG004","title":"50 mg BID"},{"description":"ASN002 75 mg BID","id":"OG005","title":"75 mg BID"},{"description":"ASN002 100 mg BID","id":"OG006","title":"100 mg BID"},{"description":"ASN002 80 mg QD","id":"OG007","title":"80 mg QD"},{"description":"ASN002 120 mg QD","id":"OG008","title":"120 mg QD"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"First 29 days","title":"Objective Response Rate","type":"PRIMARY","unitOfMeasure":"Participants"}